Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Merck
McKinsey
Harvard Business School
Colorcon

Make Better Decisions

your single source for accurate, objective, and timely intelligence

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Solutions designed for all your needs

Reliable primary data + expert analysis. We provide answers for your burning questions

See Plans and Pricing →

Generic First Entrants
Generic First Entrants

How do we identify generic entrants before they get FDA approval?

Read Article
Law Firm Business Development
Law Firm Business Development

Identify clients for patent litigation support.

Read Article
Day 181 Generic Drug Launch
Day 181 Generic Drug Launch

A Fast and Cheap Way to Find Generic Entry Opportunities

Read Article
Drug Sales Histories and Profiles

Refine Your Market-Entry Strategy

  • Assess market potential through historic sales figures
  • Evaluate buyer power with data on reimbursement segmentation
  • Align distribution methods with information on where and how drugs are purchased
Drug Prices

Find and Evaluate Business Opportunities

  • Assess levels of generic competition
  • Use drug price ranges to evaluate price elasticity
  • Determine optimal prices before launch
Global Drug Patents in 134 Countries

Global Drug Patents

  • Drug Patents in 134 Countries
  • Evaluate branded and generic market opportunities globally
Drug Patent Litigation

Get Confidential Royalty and Settlement Terms

  • Study failed patent challenges to develop a better strategy
  • Collect competitive intelligence by examining contractual disputes
  • Track litigation to anticipate early generic entry
Find Generic Drug Entry Opportunities

Find Generic Drug Entry Opportunities

  • Inform portfolio management decisions
  • Sector landscaping and due diligence
  • Track drugs in development and explore new indications for existing drugs
Track 505(b)(2) entrants

Monitor 505(b)(2) activity

  • Anticipate 505(b)(2) approvals
  • Track OTC-switches, new formulations, and other drug improvements
  • Strengthen new formulation patents by studying prior claims and litigation

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Medtronic
Dow
Merck
Johnson and Johnson